glp 1 weight loss mechanism of action Let me show you something. When people talk about GLP-1 medications, the conversation almost always collapses into one phrase. They suppress your appetite. That is not wrong. It is incomplete. And the Frontiers | GLP−1 receptor agonists

This explosive growth is driven by surging obesity rates, a paradigm shift in medical perceptionfrom lifestyle choice to chronic diseaseand groundbreaking pharmaceutical advancements

Food and Drug Administration (FDA) and the Central Drugs Standard Control Organisation (CDSCO) in India, have approved GLP-1 RAs based on their safety and efficacy 3 , 6

Mounjaro (tirzepatide) : The SURMOUNT trials demonstrated even greater efficacy, with average weight loss of 22.5% at the highest dose after 72 weeks

The IRRs of pancreatic cancer (0.74

The use of GLP-1 RAs for treating OSA offers a promising alternative or adjunct to CPAP, particularly in patients with obesity or metabolic dysfunction

Extra fat cells act like mini chemical factories, releasing hormones and inflammatory messengers called cytokines, such as interleukin-6 (IL-6), Tumor necrosis factor alpha (TNF-alpha), interleukin-17 (IL-17), and others